Propranolol Plasma Levels and Relief of Migraine
- 1 January 1985
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 42 (1) , 46-48
- https://doi.org/10.1001/archneur.1985.04060010052015
Abstract
• The relationship between propranolol and 4-hydroxypropranolol plasma concentrations and relief of migraine was assessed in 17 patients during treatment with oral racemic propranolol hydrochloride in doses of 40 to 240 mg /day. Propranolol decreased the migraine index more than 70% in 13 patients: five patients at a dosage of 40 mg/day, five patients at a dosage of 120 mg/day, and three patients at a dosage of 240 mg/ day. Three patients did not achieve a good improvement of migraine at any of the doses used. The relief of migraine was not directly related to the propranolol and 4-hydroxypropranolol plasma concentrations.Keywords
This publication has 7 references indexed in Scilit:
- Simple and rapid determination of propranolol and its active metabolite, 4-hydroxypropranolol, in human plasma by liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Pharmacology of MigraineAnnual Review of Pharmacology and Toxicology, 1981
- Amitriptyline in Migraine ProphylaxisArchives of Neurology, 1979
- Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptorNature, 1977
- SHORT-TERM CLINICAL TRIAL of PROPRANOLOL IN RACEMIC FORM (INDERAL), D-PROPRANOLOL and PLACEBO IN MIGRAINEActa Neurologica Scandinavica, 1976
- Clinical pharmacology of propranolol.Circulation, 1975
- The treatment of migraine with propranololNeurology, 1972